The U.S. FDA grants approval for the Pfizer–BioNTech COVID-19 vaccine for people aged between 12 and 17. (Reuters) COVID-19 vaccination in the United StatesCOVID-19 pandemic in the United States2022 monkeypox outbreak link embed save